Anantha Shekhar, MD, PhD
Indiana University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anantha Shekhar, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:48 UTC. Open this list on ClinicalTrials.gov
- N/ANCT00741416 · Biorepository: Indiana Health StudyFairbanks Institute · unknown · Coronary Artery Disease, Heart Disease, Healthy
- Ph2NCT00235274 · Effects of RG1068 (Secretin) on Information Processing in SchizophreniaIndiana University · completed · Schizophrenia · principal investigator
- Ph3NCT00216281 · Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant SchizophreniaIndiana University · terminated · Schizophrenia · principal investigator
- Ph2NCT00216294 · Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive DisorderIndiana University · completed · Obsessive Compulsive Disorder (OCD) · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.